mRNA vaccines encoding these tumor antigens (THBS2, FSTL3, TNNT1, BGN, CTHRC1, and NOX4) induce a cell-mediated immune response and humoral immune response that are beneficial for efficient clearance of cancer cells. The gene discussed is FSTL3; the disease is cancer.